← Leaderboards
James Seibold
University Of Michigan At Ann Arbor
$9,227
Attributed
$9,227
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.7K · FY2006–07$10K$7.5K$5K$2.5K$0
'06
'07
Funding mix
By agency
NIH$9,227 · 3
By mechanism
M01$9,227 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Theodore S Lawrence$30,022,406
- Jeffrey S Chamberlain$54,800,495
- Max S. Wicha$49,028,071
- Matthias Kretzler$40,447,062
- Shaomeng Wang$36,139,079
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceImmune SystemInstitutionResourcesPharmaceutical PreparationsAutoimmune DiseasesGrantInfectionOrganResearch PersonnelUnited States National Institutes Of HealthThinking, FunctionComputer Retrieval Of Information On Scientific Projects DatabaseIntravenousAdverse EffectsFundingBaseCaringCancer PatientAutologousBone MarrowDermatomyositisBlood CellsAutoimmune Process
Grant awards (3)
SCLERODERMA CYCLOPHOSPHAMIDE OR TRANSPLANTATION (SCOT) STUDY$3,616
M01 · FY2007 · RR · contact PI
TRIAL OF INTRAVENOUS RITUXIMAB IN TREATMENT OF REFRACTORY MYOSITIS$2,035
M01 · FY2007 · RR · contact PI
HIGH-DOSE IMMUNTX W/ AUTOLOGOUS STEM CELL RESCUE FOR SYSTEMIC SCLEROSIS$3,576
M01 · FY2006 · RR · contact PI